Literature DB >> 31541928

Construction of a comprehensive nutritional index and its correlation with quality of life and survival in patients with nasopharyngeal carcinoma undergoing IMRT: A prospective study.

Jun Deng1, Yan He2, Xue-Song Sun1, Jian-Mei Li1, Ming-Zhu Xin1, Wen-Qiong Li1, Zhen-Xiu Li1, Shan Nie1, Cong Wang1, Yan-Zhu Li1, Li-Ping Chen1, Lin-Min Chen1, Shi-Heng Zhu1, Jia-Wen Li1, Wen Hu1, Yu-Ying Fan1, Shan-Shan Guo1, Hai-Qiang Mai1.   

Abstract

OBJECTIVES: The aim of this study was to investigate the relationship between a comprehensive nutritional index (CNI) and QoL in patients with NPC who undergo IMRT and to explore the relationship between CNI and survival.
METHODS: 359 patients with newly diagnosed NPC were enrolled. QoL was assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 and Quality of Life Questionnaire Head and Neck Cancer Module at three time points: before, immediately after, and 3 months after IMRT. The CNI comprised five values including body mass index, usual body weight percentage, hemoglobin, albumin, and total lymphocyte count, and was evaluated before and immediately after IMRT. The correlation between the CNI and QoL and the effect of CNI on prognosis were analysed.
RESULTS: QoL and CNI scores decreased remarkably after IMRT (P < 0.05). The CNI was quite low in patients with III-IV clinical tumor stage and those undergoing induction chemotherapy plus concurrent chemotherapy. After IMRT, lower CNI score correlated worse QoL (P < 0.05). The Kaplan-Meier curve indicated that patients with lower CNI had significantly poorer survival outcomes (P = 0.02). In multivariate analysis, CNI remained an independent prognostic factor of overall survival (P = 0.046).
CONCLUSIONS: CNI can be recommended as an appropriate indicator reflecting the integrated nutrition status of NPC patients. Low CNI was associated with poor QoL and predicted a poor survival outcome. More interventions should be taken to improve the nutrition status of NPC patients to improve QoL and enhance survival outcomes.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Intensity-modulated radiation therapy; Nasopharyngeal carcinoma; Nutrition; Quality of life; Survival

Year:  2019        PMID: 31541928     DOI: 10.1016/j.oraloncology.2019.09.014

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  5 in total

1.  Applicability of the Nutrition Risk Screening 2002 Combined with a Patient-Generated Subjective Global Assessment in Patients with Nasopharyngeal Carcinoma.

Authors:  Xiaoxian Pan; Caihong Wang; Rong Li; Li Su; Mingwei Zhang; Chuanshu Cai; Shiping Liu; Weijian Zhang; Jihong Song; Jinsheng Hong
Journal:  Cancer Manag Res       Date:  2020-09-09       Impact factor: 3.989

2.  Modeling Sarcopenia to Predict Survival for Patients With Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy.

Authors:  Xin Hua; Wang-Zhong Li; Xin Huang; Wen Wen; Han-Ying Huang; Zhi-Qing Long; Huan-Xin Lin; Zhong-Yu Yuan; Ling Guo
Journal:  Front Oncol       Date:  2021-03-11       Impact factor: 6.244

3.  A Model Combining Skeletal Muscle Mass and a Hematological Biomarker to Predict Survival in Patients With Nasopharyngeal Carcinoma Undergoing Concurrent Chemoradiotherapy.

Authors:  Han-Ying Huang; Fei Lin; Xiao-Yu Chen; Wen Wen; Shuang-Yan Xie; Zhi-Qing Long; Ling Guo; Huan-Xin Lin
Journal:  Front Oncol       Date:  2021-05-18       Impact factor: 6.244

4.  A Scoring System Based on Nutritional and Inflammatory Parameters to Predict the Efficacy of First-Line Chemotherapy and Survival Outcomes for De Novo Metastatic Nasopharyngeal Carcinoma.

Authors:  Wang-Zhong Li; Xin Hua; Shu-Hui Lv; Hu Liang; Guo-Ying Liu; Nian Lu; Wei-Xin Bei; Wei-Xiong Xia; Yan-Qun Xiang
Journal:  J Inflamm Res       Date:  2021-03-10

5.  Association of Systemic Inflammation and Malnutrition With Survival in Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy: Results From a Multicenter Cohort Study.

Authors:  Xin Wang; Ming Yang; Yizhong Ge; Meng Tang; Benqiang Rao; Yongbing Chen; Hongxia Xu; Minghua Cong; Zengqing Guo; Hanping Shi
Journal:  Front Oncol       Date:  2021-10-26       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.